CHKGF(CHKGF)
CHKGF
No analyst ratings available
No analyst price targets available for CHKGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $56.71B | $44.96B | $68.04B | $85.50B |
| Low | $47.74B | $34.29B | $54.59B | $68.60B |
| High | $68.69B | $54.83B | $82.70B | $103.91B |
| EBITDA Avg | $22.84B | $18.11B | $27.41B | $34.44B |
| Low | $19.23B | $13.81B | $21.99B | $27.63B |
| High | $27.67B | $22.09B | $33.31B | $41.86B |
| EBIT Avg | $20.43B | $16.20B | $24.51B | $30.80B |
| Low | $17.20B | $12.35B | $19.67B | $24.71B |
| High | $24.75B | $19.75B | $29.79B | $37.44B |
| Net Income Avg | $15.44B | $13.53B | $15.85B | $17.75B |
| Low | $11.47B | $10.06B | $11.77B | $13.19B |
| High | $19.76B | $17.32B | $20.28B | $22.72B |
| EPS Avg | $4.41 | $3.87 | $4.53 | $5.07 |
| Low | $3.28 | $2.87 | $3.36 | $3.77 |
| High | $5.65 | $4.95 | $5.79 | $6.49 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 1 / 1 | 2 / 1 |